{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:52:02Z","timestamp":1793976722019,"version":"4.8.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004004.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000}}],"reference-count":74,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004004.pub4","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T01:11:17Z","timestamp":1598404277000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Radiotherapy for neovascular age-related macular degeneration"],"prefix":"10.1002","volume":"2020","author":[{"given":"Jennifer R","family":"Evans","sequence":"additional","affiliation":[{"name":"Cochrane Eyes and Vision, ICEH; London School of Hygiene & Tropical Medicine; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinedu","family":"Igwe","sequence":"additional","affiliation":[{"name":"Sutton Hospital; Surrey UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L","family":"Jackson","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; King's College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Chong","sequence":"additional","affiliation":[{"name":"Oxford Eye Hospital; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD004004.pub4-BIB0001|cit1","first-page":"326","article-title":"The results of randomized controlled trial of low-dose radiation for wet-type age-related macular degeneration on a 1-year term basis","volume":"107","author":"Treatment of Age-related Macular Degeneration with Low-dose Radiation Therapy Study Group","year":"2003","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"5","key":"10.1002\/14651858.CD004004.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ajo.2004.06.081","article-title":"The age-related macular degeneration radiotherapy trials (AMDRT): one year results from a pilot study","volume":"138","author":"Marcus","year":"2004","journal-title":"American Journal of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD004004.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s003470050349","article-title":"Radiotherapy of exudative senile macular degeneration. A prospective controlled study","volume":"95","author":"Anders","year":"1998","journal-title":"Ophthalmologe"},{"issue":"5","key":"10.1002\/14651858.CD004004.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s004170050085","article-title":"A randomised controlled trial of efficacy of radiation therapy in the control of subfoveal neovascularisation in age-related macular degeneration: radiation verses observation","volume":"236","author":"Bergink","year":"1998","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD004004.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00417-002-0428-4","article-title":"Side effects after radiotherapy of age-related macular degeneration with the Nijmegen technique","volume":"240","author":"Hoyng","year":"2002","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD004004.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ophtha.2012.07.068","article-title":"Epimacular brachytherapy for neovascular age-related macular degeneration: a randomized, controlled trial (CABERNET)","volume":"120","author":"Dugel","year":"2013","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD004004.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.ophtha.2013.01.074","article-title":"Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET): Fluorescein angiography and optical coherence tomography","volume":"120","author":"Jackson","year":"2013","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD004004.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0002-9394(99)00038-0","article-title":"Randomised trial of radiation for age-related macular degeneration","volume":"127","author":"Char","year":"1999","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD004004.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9394(02)01821-4","article-title":"Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trial","volume":"134","author":"Ciulla","year":"2002","journal-title":"American Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD004004.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1014445524293","article-title":"Radiotherapy for age-related macular degeneration: is there a benefit for classic CNV?","volume":"24","author":"Eter","year":"2002","journal-title":"International Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD004004.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/bjophthalmol-2018-311865","article-title":"Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial","volume":"103","author":"Freiberg","year":"2019","journal-title":"British Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD004004.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.ophtha.2013.02.016","article-title":"Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study","volume":"120","author":"Jackson","year":"2013","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD004004.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ophtha.2014.07.043","article-title":"Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID study","volume":"122","author":"Jackson","year":"2015","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD004004.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.ophtha.2013.01.074","article-title":"Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET) fluorescein angiography and optical coherence tomography","volume":"120","author":"Jackson","year":"2013","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD004004.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/IAE.0000000000000283","article-title":"Stereotactic radiotherapy for wet age-related macular degeneration (INTREPID): influence of baseline characteristics on clinical response","volume":"35","author":"Jackson","year":"2015","journal-title":"Retina"},{"issue":"4","key":"10.1002\/14651858.CD004004.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ophtha.2004.11.029","article-title":"Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized study","volume":"112","author":"Jaakkola","year":"2005","journal-title":"Ophthalmology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004004.pub4-BIB0017|cit17","first-page":"7","article-title":"Macular degeneration treatment at Clatterbridge Centre for oncology: treatment and preliminary results","volume":"17","author":"Kacperek","year":"2001","journal-title":"Physica Medica"},{"issue":"5","key":"10.1002\/14651858.CD004004.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0002-9394(00)00534-1","article-title":"Age-related macular degeneration: long-term results of radiotherapy for subfoveal neovascular membranes","volume":"130","author":"Kobayashi","year":"2000","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD004004.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00006982-199911000-00008","article-title":"Sham radiation in clinical trials assessing radiotherapy for exudative age-related macular degeneration","volume":"19","author":"Marcus","year":"1999","journal-title":"Retina"},{"issue":"19","key":"10.1002\/14651858.CD004004.pub4-BIB0020|cit20","first-page":"171","article-title":"External beam irradiation of subfoveal choroidal neovascularisation complicating age-related macular degeneration","volume":"1","author":"Marcus","year":"2001","journal-title":"Archives of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD004004.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ophtha.2016.02.028","article-title":"Epimacular brachytherapy for previously treated neovascular age-related macular degeneration (MERLOT): a phase 3 randomized controlled trial","volume":"123","author":"Jackson","year":"2016","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD004004.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaophthalmol.2020.2309","article-title":"Evaluation of month-24 efficacy and safety of epimacular brachytherapy for previously treated neovascular age-related macular degeneration: the MERLOT randomized clinical trial","volume":"138","author":"Jackson","year":"2020","journal-title":"JAMA Ophthalmology"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0023|cit23","unstructured":"Lu J Daftari I Mishra K Moshiri A Park SS Changes in subretinal hyperreflective material in phase I\/II study of proton beam irradiation combined with anti-VEGF therapy for exudative age-related macular degeneration Investigative Ophthalmology and Visual Science 2017 58 8 ARVO E abstract 4831"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0024|cit24","unstructured":"Prospective trial of proton beam combined with anti-VEGF therapy for exudative age-related macular degeneration (AMD) (PBAMD2) clinicaltrials.gov\/ct2\/show\/NCT01213082"},{"issue":"3","key":"10.1002\/14651858.CD004004.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.oret.2016.11.003","article-title":"Phase I\/II randomized study of proton beam with anti-vascular endothelial growth factor for exudative age-related macular degeneration: one-year results","volume":"1","author":"Osmanovic","year":"2017","journal-title":"Ophthalmology Retina"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0026|cit26","unstructured":"Wong S Daftari I Mishra K Migacz J V Gorczynska I Fluorescein and OCT angiographic evaluation of choroidal neovascular membrane following proton beam and intravitreal anti-VEGF therapy for exudative AMD: 2-year follow up Investigative Ophthalmology and Visual Science 2017 58 8 ARVO E abstract 370"},{"issue":"12","key":"10.1002\/14651858.CD004004.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00417-003-0689-6","article-title":"Visual acuity and contrast sensitivity in patients with neovascular age-related macular degeneration. Results from the Radiation Therapy for Age-Related Macular Degeneration (RAD-) Study","volume":"241","author":"Bellmann","year":"2003","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0028|cit28","unstructured":"Holz FG Unnebrink K Staudt S Voelcker HE Wannenmacher M Bellmann C Two-years results of a prospective, randomized, double-blind multicenter trial on radiation therapy for neovascular ARMD American Academy of Ophthalmology 2000 115"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0029|cit29","unstructured":"Holz FG Voelcker HE Engenhart-Cabillic R Bellmann C Unnebrink K Debus J A prospective randomized, controlled, double-blind multicenter trial on radiation therapy for subfoveal CNV secondary to ARMD American Academy of Ophthalmology 1999 247 8"},{"issue":"12","key":"10.1002\/14651858.CD004004.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0161-6420(99)90522-5","article-title":"A prospective, randomised, double-masked trial on radiation therapy for neovascular age-related macular degeneration","volume":"106","author":"The Radiation Therapy for Age-Related Macular Degeneration (RAD) Group","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"275 (A1015)","DOI":"10.1016\/S0959-8049(01)81508-2","article-title":"A prospective randomized, double-blind multicenter-trial on radiation therapy for neovascular age-related macular degeneration","volume":"37","author":"Vacha","year":"2001","journal-title":"European Journal of Cancer"},{"issue":"8","key":"10.1002\/14651858.CD004004.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/archopht.120.8.1029","article-title":"Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration","volume":"120","author":"Hart","year":"2002","journal-title":"Archives of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD004004.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/bjo.2003.030445","article-title":"Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2","volume":"89","author":"Stevenson","year":"2005","journal-title":"British Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD004004.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1013047722865","article-title":"A 5-year follow-up study for distance visual acuity after low dose radiation on subfoveal choroidal neovascularization in age-related macular degeneration","volume":"103","author":"Valmaggia","year":"2001","journal-title":"Documenta Ophthalmologica"},{"issue":"4","key":"10.1002\/14651858.CD004004.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9394(02)01336-3","article-title":"Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial","volume":"133","author":"Valmaggia","year":"2002","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD004004.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/bjo.2008.145912","article-title":"Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration","volume":"93","author":"Avila","year":"2009","journal-title":"British Journal of Ophthalmology"},{"issue":"933","key":"10.1002\/14651858.CD004004.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1259\/bjr\/17631422","article-title":"A phase I trial of stereotactic external beam radiation for subfoveal choroidal neovascular membranes in age-related macular degeneration","volume":"78","author":"Barak","year":"2005","journal-title":"British Journal of Radiology"},{"issue":"1","key":"10.1002\/14651858.CD004004.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01203296","article-title":"Radiation therapy for age-related subfoveal choroidal neovascular membranes","volume":"90","author":"Bergink","year":"1995","journal-title":"Documenta Ophthalmologica"},{"issue":"2, Suppl 1","key":"10.1002\/14651858.CD004004.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"332 (A2184)","DOI":"10.1016\/S0360-3016(97)80951-0","article-title":"Strontium-90 brachytherapy for exudative, age related macular degeneration: a pilot study","volume":"39","author":"Brown","year":"1997","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"6","key":"10.1002\/14651858.CD004004.pub4-BIB0040|cit40","first-page":"398","article-title":"External-beam radiation therapy for age-related macular degeneration: Two years' follow-up results at a total dose of 20 Gy in 10 fractions","volume":"22","author":"Churei","year":"2004","journal-title":"Radiation Medicine"},{"issue":"12","key":"10.1002\/14651858.CD004004.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00417-001-0391-5","article-title":"External beam radiotherapy for age-related macular degeneration causes transient objective changes in tear-film function","volume":"239","author":"Eter","year":"2001","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0042|cit42","unstructured":"Friedrichsen EJ Slater JD Hagele JE Chan CK Yonemoto LT Garcia C A Proton beam irradiation of subfoveal choroidal neovascularization: a pilot study of single-dose 800 cGy and 1400 cGy American Academy of Ophthalmology 1996 135"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0043|cit43","first-page":"186","article-title":"A study to evaluate the safety and feasibility of radiotherapy and bevacizumab (Avastin) for the treatment of subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD)","author":"Heier","year":"2008","journal-title":"The Macular Society"},{"issue":"9","key":"10.1002\/14651858.CD004004.pub4-BIB0044|cit44","first-page":"1563","article-title":"Evaluation of the early-phase response of neovascular membrane in age-related macular degeneration to low-dose radiation","volume":"51","author":"Honjo","year":"1997","journal-title":"Japanese Journal of Clinical Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD004004.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/eye.2011.351","article-title":"Cost analysis comparing adjuvant epimacular brachytherapy with anti-VEGF monotherapy for the management of neovascular age-related macular degeneration","volume":"26","author":"Jackson","year":"2012","journal-title":"Eye"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0046|cit46","first-page":"567","article-title":"Long term effects of radiation treatment for age-related macular degeneration","volume":"52","author":"Mandai","year":"1998","journal-title":"Japanese Journal of Clinical Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD004004.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0021-5155(00)00217-3","article-title":"Long-term outcome after radiation therapy for subfoveal choroidal neovascularization associated with age-related macular degeneration","volume":"44","author":"Mandai","year":"2000","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD004004.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/bjo.88.1.114","article-title":"Radiotherapy for recurrent choroidal neovascularisation complicating age related macular degeneration","volume":"88","author":"Marcus","year":"2004","journal-title":"British Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD004004.pub4-BIB0049|cit49","first-page":"803","article-title":"Low-dose radiation, therapy for choroidal neovascularization in age-related macular degeneration","volume":"100","author":"Matsuhashi","year":"1996","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"6","key":"10.1002\/14651858.CD004004.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0021-5155(00)00280-X","article-title":"Radiation therapy for small choroidal neovascularization in age-related macular degeneration","volume":"44","author":"Matsuhashi","year":"2000","journal-title":"Japanese Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0051|cit51","unstructured":"Proton radiation therapy for macular degeneration clinicaltrials.gov\/ct2\/show\/NCT01833325"},{"issue":"10","key":"10.1002\/14651858.CD004004.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/BF00946943","article-title":"Low-dose radiation therapy for age-related macular degeneration","volume":"235","author":"Postgens","year":"1997","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0053|cit53","unstructured":"Reichel E Farah M Duprat JP Avila M Fujii GY A study to evaluate the safety and feasibility of radiotherapy and bevacizumab (Avastin) for the treatment of subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration Investigative Ophthalmology and Visual Science 2007 48 13 ARVO E Abstract 3657"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0054|cit54","first-page":"89","article-title":"Brachytherapy - optional treatment for choroidal neovascularization secondary to age-related macular degeneration","volume":"25 Suppl","author":"Saric","year":"2001","journal-title":"Collegium Antropologicum"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0055|cit55","first-page":"1821","article-title":"Radiation treatment for age-related macular degeneration","volume":"50","author":"Taniguchi","year":"1996","journal-title":"Japanese Journal of Clinical Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD004004.pub4-BIB0056|cit56","first-page":"112","article-title":"Radiotherapy for choroidal neovascularization (CNV) in age-related macular degeneration (AMD)","volume":"216","author":"Tholen","year":"2000","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"issue":"10","key":"10.1002\/14651858.CD004004.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s003470050337","article-title":"Radiotherapy for choroidal neovascularization in age-related macular degeneration. A pilot study using low- versus high-dose photon beam radiation","volume":"95","author":"Tholen","year":"1998","journal-title":"Ophthalmologe"},{"issue":"11","key":"10.1002\/14651858.CD004004.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.ophtha.2006.05.036","article-title":"Proton beam irradiation for neovascular age-related macular degeneration","volume":"113","author":"Zambarakji","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0059|cit59","unstructured":"Stereotactic radiotherapy for wet AMD (STAR) clinicaltrials.gov\/ct2\/show\/NCT02243878"},{"issue":"3","key":"10.1002\/14651858.CD004004.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/ICU.0b013e32835f8eaa","article-title":"Combination therapy for the treatment of neovascular age-related macular degeneration","volume":"24","author":"Englander","year":"2013","journal-title":"Current Opinion in Ophthalmology"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0061|cit61","volume-title":"The Epidemiology of Eye Disease","author":"Evans","year":"2012"},{"issue":"12","key":"10.1002\/14651858.CD004004.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Global Health"},{"issue":"2","key":"10.1002\/14651858.CD004004.pub4-BIB0063|cit63","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0064|cit64","unstructured":"GRADEpro GDT GRADE Working Group, McMaster University"},{"issue":"10","key":"10.1002\/14651858.CD004004.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/bjo.83.10.1115","article-title":"A vision specific functional index for use in patients with age related macular degeneration","volume":"83","author":"Hart","year":"1999","journal-title":"British Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD004004.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/IAE.0000000000001142","article-title":"Meta-analysis of real-world outcomes of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration","volume":"36","author":"Kim","year":"2016","journal-title":"Retina"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD004004.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijrobp.2012.07.2352","article-title":"Radiation therapy for neovascular age-related macular degeneration","volume":"85","author":"Kishan","year":"2013","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"5","key":"10.1002\/14651858.CD004004.pub4-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012208.pub2","article-title":"Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration","author":"Li","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000351061","article-title":"Radiation therapy: age-related macular degeneration","volume":"52","author":"Mendez","year":"2013","journal-title":"Developments in Ophthalmology"},{"key":"10.1002\/14651858.CD004004.pub4-BIB0071|cit71","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"3","key":"10.1002\/14651858.CD004004.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/08820538.2011.554486","article-title":"Radiation treatment for age-related macular degeneration","volume":"26","author":"Silva","year":"2011","journal-title":"Seminars in Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD004004.pub4-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004004.pub3","article-title":"Radiotherapy for neovascular age-related macular degeneration","author":"Evans J","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004004.pub4-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004004.pub2","article-title":"Radiotherapy for neovascular age-related macular degeneration","author":"Sivagnanavel","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T15:34:29Z","timestamp":1702913669000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004004.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":74,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004004.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]}}}